Anna Babayan
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 7
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
- Oncology 5
- Cancer Cells and Metastasis 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Klaus Pantel (10 shared papers)Simone Anfossi (1 shared paper)George A. Călin (1 shared paper)Simon Andreas Joosse (4 shared papers)Volkmar Müller (3 shared papers)Juliane Hannemann (1 shared paper)Prof Catherine Alix-Panabières (2 shared papers)Laure Cayrefourcq (1 shared paper)
- Journals
- Cancers (3 papers)Oncotarget (2 papers)Clinical Chemistry (2 papers)Molecular Imaging and Biology (1 paper)Scientific Reports (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Anna Babayan
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 738
- Oncology 423
- Molecular Biology 604
- Pulmonary and Respiratory Medicine 185
- Immunology and Allergy 20
Countries citing papers authored by Anna Babayan
This map shows the geographic impact of Anna Babayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Babayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Babayan more than expected).
Fields of papers citing papers by Anna Babayan
This network shows the impact of papers produced by Anna Babayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Babayan. The network helps show where Anna Babayan may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Babayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 377 | |
| 2 | 2019 | 130 | |
| 3 | 2019 | 119 | |
| 4 | 2013 | 114 | |
| 5 | 2019 | 109 | |
| 6 | 2018 | 90 | |
| 7 | 2018 | 69 | |
| 8 | 2016 | 62 | |
| 9 | 2019 | 34 | |
| 10 | 2019 | 20 | |
| 11 | 2016 | 18 | |
| 12 | 2020 | 17 | |
| 13 | 2018 | 16 | |
| 14 | 2019 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2011 | 0 |
About Anna Babayan
Anna Babayan is a scholar working on Cancer Research, Oncology, Molecular Biology, Biotechnology and Pathology and Forensic Medicine, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Cancer Cells and Metastasis (4 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Glycosylation and Glycoproteins Research (1 paper), Microfluidic and Bio-sensing Technologies (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Cancer Research (738 citations), Oncology (423 citations), Molecular Biology (604 citations), Pulmonary and Respiratory Medicine (185 citations) and Immunology and Allergy (20 citations). Anna Babayan has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Klaus Pantel, Simone Anfossi, George A. Călin, Simon Andreas Joosse, Volkmar Müller, Juliane Hannemann, Prof Catherine Alix-Panabières, Laure Cayrefourcq, Eric Assénat and Thibault Mazard. Their work appears in journals such as Cancers, Oncotarget, Clinical Chemistry, Molecular Imaging and Biology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.